bcr2480 1465-5411 Correction <p>Correction: PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer</p> WishartCGordongordon.wishart@addenbrookes.nhs.uk AzzatoMElizabeth GreenbergCDavid RashbassJem KearinsOlive LawrenceGill CaldasCarlos PharoahDPPaul

Cambridge Breast Unit, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, UK

Strangeways Research Laboratory, Department of Oncology, University of Cambridge, Worts Causeway, Cambridge CB1 8RN, UK

Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA

Eastern Cancer Registration and Information Centre (ECRIC), Unit C, Magog Court, Shelford Bottom, Hinton Way, Cambridge CB22 3AD, UK

West Midlands Cancer Intelligence Unit, Public Health Building, The University of Birmingham, Birmingham, B15 2TT, UK

Department of Oncology, University of Cambridge, and Functional Breast Cancer Genomics Laboratory, Cancer Research UK Cambridge Research Institute, Li Ka-Shing Centre, Robinson Way, Cambridge CB2 0RE, UK

National Institute of Health Research (NIHR) Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, UK

 Breast Cancer Research 1465-5411 2010 12 2 401 http://breast-cancer-research.com/content/12/2/401 See related research by Wishhart et al., http://breast-cancer-research.com/content/12/1/R1 10.1186/bcr248020236450 132010 2010BioMed Central Ltd

Following the publication of our article 1 we noticed an error in Table 1 relating to the number of patients who received adjuvant therapy. The correct table is given here (Table 1).

<p>Table 1</p>

Patient characteristics for model development (ECRIC) and validation (WMCIU) cohorts

ECRIC

WMCIU

Total Number of Subjects

5,694

5,468

Total time at risk (years)

31,904

25,917

Median follow-up (years)*

5.65

(0.04-8.00)†

4.85

(0.07-8.00)†

Number of breast cancer deaths

737

668

Number of other deaths

338

287

Annual breast cancer mortality rate

0.023

(0.021-0.025)‡

0.026

(0.024-0.028)‡

5-year breast cancer survival rate

0.89

(0.88-0.90)‡

0.88

(0.87-0.89)‡

Median age at diagnosis, years

58

(23-95)†

58

(22-93)†

Number

%

Number

%

Age, years

<35

111

2

108

2

35-49

1,172

21

1,195

22

50-64

2,630

46

2,393

44

65-74

1,124

20

1,101

20

75+

657

12

671

12

Nodal status

0

3,532

62

3,184

58

1

741

13

746

14

2-4

806

14

792

14

5-9

380

7

451

8

10+

235

4

295

5

Tumour size, mm

<10

625

11

485

9

10-19

2,310

41

2,136

39

20-29

1,627

29

1,566

29

30-49

845

15

923

17

50+

287

5

358

7

Grade

I

1,005

18

1,017

19

II

2,927

51

2,442

45

III

1,762

31

2,009

37

ER Status

ER negative

991

17

1,116

20

ER positive

4,703

83

4,352

80

Adjuvant therapy

None

643

11

1,520

28

Chemotherapy only

783

14

1,542

28

Endocrine therapy

3,146

55

1,827

33

Combined chemoendocrine

1,122

20

579

11

Screen detected

Yes

1,621

28

1,256

23

No

4,073

72

4,212

77

*Follow-up censored at 8 years

†Range of variable

‡95 CI

 <p>PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer</p>WishartGCAzzatoEMGreenbergDCRashbassJKearinsOLawrenceGCaldasCPharoahPDBreast Cancer Res201012R110.1186/bcr2464288041920053270